Therapeutic potential of chalcones as cardiovascular agents

Life Sciences
Debarshi Kar Mahapatra, Sanjay Kumar Bharti

Abstract

Cardiovascular diseases are the leading cause of death affecting 17.3 million people across the globe and are estimated to affect 23.3 million people by year 2030. In recent years, about 7.3 million people died due to coronary heart disease, 9.4 million deaths due to high blood pressure and 6.2 million due to stroke, where obesity and atherosclerotic progression remain the chief pathological factors. The search for newer and better cardiovascular agents is the foremost need to manage cardiac patient population across the world. Several natural and (semi) synthetic chalcones deserve the credit of being potential candidates to inhibit various cardiovascular, hematological and anti-obesity targets like angiotensin converting enzyme (ACE), cholesteryl ester transfer protein (CETP), diacylglycerol acyltransferase (DGAT), acyl-coenzyme A: cholesterol acyltransferase (ACAT), pancreatic lipase (PL), lipoprotein lipase (LPL), calcium (Ca(2+))/potassium (K(+)) channel, COX-1, TXA2 and TXB2. In this review, a comprehensive study of chalcones, their therapeutic targets, structure activity relationships (SARs), mechanisms of actions (MOAs) have been discussed. Chemically diverse chalcone scaffolds, their derivatives including structural man...Continue Reading

References

Dec 1, 1985·Circulation·G A FitzGeraldA K Pedersen
May 1, 1968·Journal of Pharmaceutical Sciences·G P ShermanG V Rossi
Mar 15, 2003·Clinical Therapeutics·Cindy B LevineVeronica Ludensky
Aug 24, 2004·Bioscience, Biotechnology, and Biochemistry·Taichi YamamotoMamoru Kikuchi
Oct 16, 2004·The Journal of Pharmacy and Pharmacology·Horng-Huey KoChun-Nan Lin
Feb 26, 2005·Journal of Natural Products· Atta-ur-RahmanM Iqbal Choudhary
May 3, 2006·Biological & Pharmaceutical Bulletin·Yeon Sil LeeSang Hoon Jung
Sep 30, 2006·Archiv der Pharmazie·Lorena SantosRosendo Augusto Yunes
Aug 9, 2007·Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine·Kensuke Usuki
Sep 14, 2007·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Fátima de Campos-BuzziValdir Cechinel-Filho
Oct 30, 2007·Bioorganic & Medicinal Chemistry·Xiao-Ling LiuMei-Lin Go
Nov 23, 2007·Bioorganic & Medicinal Chemistry Letters·Oleg V YarishkinKi Hun Park
Jun 19, 2008·Journal of Natural Products·Nobuwa AokiShinji Ohta
Oct 2, 2008·British Journal of Clinical Pharmacology·J M Ritter
Aug 12, 2009·Der Urologe. Ausg. A·K F Hilgers
Feb 20, 2010·Bioorganic & Medicinal Chemistry Letters·Marco BonesiFrancesco Menichini
Jun 23, 2010·European Journal of Medicinal Chemistry·Xiaowu DongYongzhou Hu
Feb 15, 2011·Phytomedicine : International Journal of Phytotherapy and Phytopharmacology·Rahul B BirariKamlesh K Bhutani
Apr 26, 2011·Bioorganic & Medicinal Chemistry Letters·Poonam ShuklaRam Pratap
Sep 29, 2011·Biochemical and Biophysical Research Communications·Suengmok ChoYoung-Ho Jin
Nov 11, 2011·Mini Reviews in Medicinal Chemistry·S Lecour, K T Lamont
Apr 13, 2012·Bioorganic & Medicinal Chemistry Letters·Yin LuoHai-Liang Zhu
May 15, 2013·European Journal of Medicinal Chemistry·Koneni V SashidharaGitika Bhatia
Aug 15, 2013·Lipids·Shishir SrivastavaVijai Lakshmi
May 30, 2014·European Journal of Medicinal Chemistry·Koneni V SashidharaGitika Bhatia
Jul 6, 2014·Biological & Pharmaceutical Bulletin·Chien-Ming WuChun-Nan Lin

❮ Previous
Next ❯

Citations

Nov 3, 2016·Journal of Agricultural and Food Chemistry·Qin-Ge MaZhong-Wen Song
Mar 10, 2018·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Tzenge-Lien ShihChia-Feng Kuo
Jul 26, 2018·Journal of Molecular Recognition : JMR·Farideh Badalkhani-KhamsehNasser L Hadipour
Apr 30, 2019·Expert Opinion on Therapeutic Patents·Debarshi Kar MahapatraSanjay Kumar Bharti
Mar 1, 2020·International Journal of Molecular Sciences·Samuel LegeayJean-Jacques Helesbeux
Jul 24, 2018·Current Drug Discovery Technologies·Debarshi K MahapatraShovanlal Gayen
Jun 13, 2019·CNS & Neurological Disorders Drug Targets·Bijo MathewSheeba Varghese Gupta
Sep 20, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Zong-Jin PuJin-Ao Duan
Sep 30, 2020·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Beata Olas, Magdalena Bryś
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Svetlana A PopovaAleksandr V Kutchin
Jul 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana MoreiraMadalena Pinto
May 11, 2017·Chemical Reviews·Chunlin ZhuangZhenyuan Miao
Dec 14, 2017·Journal of Medicinal Chemistry·Barbara Zdrazil, Rajarshi Guha
Feb 2, 2019·Chemical Reviews·Constantinos G NeochoritisAlexander Dömling

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.

Antiparasitics

Antiparasitics are medications which are indicated for the treatment of parasitic diseases. Discover the latest research on antiparasitics here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Conduction System

The cardiac conduction system is a specialized tract of myocardial cells responsible for maintaining normal cardiac rhythm. Discover the latest research on the cardiac conduction system here.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Acute Stroke

A stroke occurs when blood supply to the brain is interrupted depriving the brain of oxygen and nutrients. This feed focuses cerebrovascular accidents including ischemic and paralytic stroke.

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Related Papers

European Journal of Medicinal Chemistry
Debarshi Kar MahapatraVivek Asati
European Journal of Medicinal Chemistry
Debarshi Kar MahapatraVivek Asati
Recent Patents on Anti-cancer Drug Discovery
Chandrabose KarthikeyanPiyush Trivedi
Nihon rinsho. Japanese journal of clinical medicine
Akira Miyazaki, Takuya Watanabe
© 2022 Meta ULC. All rights reserved